CRVO - NASDAQ

CervoMed Inc.

CRVO·NASDAQ

$5.50

-0.36%

HealthcareBiotechnology

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$50.89M

EPS-2.0200

P/E Ratio-1.16

Earnings Date03/16/2026

crvo

Net Cash Provided by Financing Activities

Last Annual Value

46.40M

3-Year CAGR

12%

5-Year CAGR

24%

10-Year CAGR

Adjust for Inflation

CervoMed Inc. Competitors Analysis of Net Cash Provided by Financing Activities

CRVO · NASDAQ

Company	Net Cash Provided by Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
CervoMed Inc. NASDAQ:CRVO	46.40M	60.9%	6.9%	38.2%
NRx Pharmaceuticals, Inc. NASDAQ:NRXP	23.28M	55.4%	-18.2%	N/A
Fortress Biotech, Inc. NASDAQ:FBIO	77.44M	33.2%	-12.3%	6.1%
OS Therapies Incorporated NYSE:OSTX	12.78M	64.4%	33.2%	N/A
Adicet Bio, Inc. NASDAQ:ACET	75.25M	583.2%	-20.9%	N/A
Clene Inc. NASDAQ:CLNN	11.52M	-35.1%	-15.7%	N/A
Werewolf Therapeutics, Inc. NASDAQ:HOWL	6.03M	-53.1%	-44.0%	N/A
MindWalk Holdings Corp. NASDAQ:HYFT	14.89M	N/A	-19.3%	N/A
Immix Biopharma, Inc. NASDAQ:IMMX	107.39M	90.8%	41.6%	N/A
PMV Pharmaceuticals, Inc. NASDAQ:PMVP	505.00K	-75.8%	-24.2%	N/A
Vaxart, Inc. NASDAQ:VXRT	4.24M	-34.7%	-49.2%	N/A

CervoMed Inc. Fair Value Envelope

CRVO · NASDAQ

Our analysis suggests that CRVO has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.5, this represents a potential HIDDEN relative to our calculated worth for CervoMed Inc..

HIDDEN

Intrinsic Value

Current Price: $5.5

Related Guides

Blog Categories

Continue your CRVO research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.